Open House Biologika Discount Contracts 2025-13-Insulin Isophan/Insulin, Normal (Human) (Combination Of Active Ingredients)

Techniker Krankenkasse Germany has Released a tender for Open House Biologika Discount Contracts 2025-13-Insulin Isophan/Insulin, Normal (Human) (Combination Of Active Ingredients) in Pharmaceuticals. The tender was released on May 12, 2025.

Country - Germany

Summary - Open House Biologika Discount Contracts 2025-13-Insulin Isophan/Insulin, Normal (Human) (Combination Of Active Ingredients)

Deadline - Jul 31, 2027

MT reference number - 108725630

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 108725630

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The TK aims to use all suitable pharmaceutical entrepreneurs to conclude discount contracts according to Section 130a (8) SGB V for the active ingredient combination of insulin-isophan/insulin, normal (human) [For the division into loose see the information on the loose]. The contract is concluded as part of the open-house process of the TK: Individual negotiations on contract content are not conducted, uniform conditions apply. The TK does not assume any exclusivity to individual contractual partners. The contract term is a maximum of 24 months starting on 01.08.2025. The contract ends at the latest on July 31, 2027, regardless of the date of the conclusion of the contract. All

Mt Ref Id - 108725630

Deadline - Jul 31, 2027

Share

Similar Tenders :